How Brand Awareness Has Evolved in Healthcare
Branding for medical device and Pharma companies is uniquely complex and increasingly competitive. Whether you’re a well-established pharmaceutical company or a startup navigating early-stage development, you must strategically balance messaging to two very different audiences: the prescribing physician and the end user.
Historically, branding efforts focused almost exclusively on clinical data, efficacy, and prescriber education. But today, the game has changed. With more informed patients, crowded digital channels, and increasing scrutiny on company ethics and culture, medical brands must do more than communicate. As a brand, you need to connect with your end user.
How Brand Awareness Has Evolved in Healthcare
Brand awareness in healthcare has never been static. It evolves and is shaped by changing consumer behaviors, regulatory shifts, technological innovations, and increasing competition across pharmaceuticals, biotech, medical devices, and healthcare services.
In the 1990s, direct-to-consumer (DTC) advertising changed the healthcare marketing landscape dramatically. Campaigns like those for Claritin (Schering-Plough) and Viagra (Pfizer) pioneered a new era where companies didn’t just speak to physicians, they connected directly with patients, building emotional ties that went beyond clinical data.1
In 1997, the FDA relaxed guidelines for DTC pharmaceutical ads, leading to a 330% increase in DTC ad spending by 2005.
National Library of Medicine
The lesson learned from this was that companies and brands need to know that trust and emotional resonance are as critical as innovation itself.
The Expansion of Brand Strategy: Beyond Consumer Advertising
To understand the modern landscape of branding in this industry, look no further than late-night television. The brand battle between Viagra and Cialis unfolded commercial after commercial. They were targeting consumers with emotional appeals, lifestyle visuals, and memorable names.
These campaigns, while medically driven, were clearly focused on building brand awareness among end users. Today, those same tactics have migrated online. The battleground now includes platforms like Instagram, YouTube, LinkedIn, X, influencers, bloggers, corporate sponsorships, and branded content, which all help both Big Pharma and startups build visibility and loyalty among a more informed audience.
But before developing a brand strategy, every company must first consider:
- Are you an established pharmaceutical or medical device company?
- Or are you an emerging brand or biotech startup?
Each path requires a different brand strategy, but all companies must ultimately answer the same challenge: How do we build a brand that is trusted, remembered, and valued?
While the prime-time ads made headlines, brand-building strategies in healthcare grew even deeper behind the scenes. Today, a unified, multi-stakeholder approach is essential.
Healthcare brand awareness now includes:
- Physicians and HCPs – through continuing education, clinical trials, and thought leadership.
- Patients and caregivers – through direct communications, support programs, and community building.
- Payers and policymakers – through evidence generation, economic impact narratives, and strategic partnerships.
- Internal audiences – through employee engagement and advocacy programs.
Brand awareness must be built intentionally at every layer of influence.
Branding for Big Pharma: From Data to Differentiation
Established companies like Johnson & Johnson, Pfizer, or GE Healthcare have long relied on scientific rigor and brand trust. For decades, success meant ensuring your product was backed by strong clinical data, promoted by a knowledgeable sales force, and approved by prescribers and hospital systems.
But that’s no longer enough.
In today’s environment, empowered patients arrive at appointments armed with research and requests. They track medical news, understand generics versus brand names, and often ask for specific products by name. This shift demands that even large organizations invest in emotional storytelling and brand identity, not just in scientific efficacy.
Examples include:
- Nexium, branded as “The Little Purple Pill”
- Advil, the official pain reliever of the NHL
- Novo Nordisk, sponsoring professional cycling teams
These became more than just ads, they’re branded environments that weave medical products into everyday life.
And today, Big Pharma is taking brand awareness even further:
- Eli Lilly’s LillyDirect – Eli Lilly launched a telehealth platform for weight-loss drugs, simplifying delivery and pricing directly to patients (Axios).
- Pfizer’s ‘Pfizer for All’ Platform – Pfizer expanded into direct-to-consumer engagement through educational content, mail-order pharmacy, and telehealth services (Financial Times).
- Abbott’s Expansion Beyond Diabetes – Abbott is pushing its glucose monitoring devices toward general wellness markets, beyond diabetes patients (Reuters).
Branding for Startup Medical Device and Biotech Companies: Telling the Right Story Early
For early-stage companies, the challenge is entirely different. With no product yet on the market and little to no brand recognition, success starts with building a compelling story from the ground up.
What’s in a Name?
Choosing the right name is one of the first critical branding decisions. A strong name differentiates your company in a crowded field of “biosciences,” “therapeutics,” and “pharmaceuticals,” communicates your mission, and leaves room for growth.
At Hummingbird Creative Group, we believe that insight + positioning = the BIG IDEA, which informs everything from your brand story to your logo to your investor pitch. For startups, your brand is not just creative. It’s what gets investors excited. It’s your narrative, your credibility, and your promise to both partners and patients.
“55% of consumers who love a brand’s story are willing to make a purchase.”
UWA | Business News
The Power of Internal Branding
While your product may still be years away, your people are already making an impression. A strong internal brand highlights your team’s expertise, passion, and vision—essential elements that inspire confidence in potential investors, partners, and patients.
“65% of consumers say that a brand’s CEO and employees influence their decision to buy.” – Accenture Study
“When executives or employees do things that are off-brand, customers pay attention.” – New Branding Statistics for 2023
What Every Company Needs: An Omni-Channel Branding Strategy
Regardless of your size, your brand must be seen, heard, and trusted across every touchpoint. That’s why an omni-channel branding strategy is critical.
For startups, this means consistently showing up across:
- Blogs
- Speaking engagements
- Investor presentations
- Earned media
For large companies, this expands into:
- Corporate sponsorships
- Strategic ad campaigns
- Influencer partnerships
- Experiential marketing
- Traditional media
Your science might be groundbreaking, but if no one knows about it, it won’t break through.
The 2010s brought another leap forward: the rise of digital-first healthcare engagement.
Professional audiences began consuming more information online. Patients became more empowered, researching conditions and treatments extensively before speaking with providers. Companies had to adapt by integrating digital seamlessly into their strategies.
Omnichannel engagement, blending webinars, social platforms, email campaigns, professional portals, digital ads, and live interactions, became the new expectation.2
70% of healthcare B2B buyers expect personalized, omnichannel engagement across multiple platforms.
McKinsey
Importantly, omnichannel is about being in the right places at the right times with relevant, trustworthy, compliant messaging.
The New Brand Awareness Model: Relationship-Driven Trust
Today’s healthcare brands must prioritize trust-building over simple exposure.
This means:
- Consistency across platforms (clinical voice aligned with patient-facing voice)
- Transparency and education (clear communication of benefits, risks, and outcomes)
- Partnerships with credible voices (KOLs, HCP advocates, patient organizations)
- Measurable impact (using data to prove value, not just awareness)
Brand awareness is about being known for something valuable.
As Edelman’s 2023 Trust Barometer3 notes, healthcare organizations that deliver consistent, reliable information see significantly higher levels of public trust.
The Hummingbird Approach: Branding that Builds Business Value
At Hummingbird Creative Group, we help with branding for medical device and pharma companies. We craft brand strategies that elevate their messaging, build trust with their audiences, and increase company value.
Whether you’re developing a product, positioning for a partnership, preparing for acquisition, or scaling for growth, we help you:
- Clarify your story
- Build your visual and verbal identity
- Forge emotional connections that move people and markets
Because in today’s fast-changing world, great branding isn’t a luxury. It’s a necessity. We believe great innovations deserve to be discovered.
If you are ready to elevate your brand’s presence with authenticity, credibility, and impact, we are ready to help. While tactics will continue to evolve, the core truth remains: Brand awareness in healthcare isn’t about chasing the latest trend. It’s about earning trust at every step of the journey.
Let’s build that trust together.
- FDA: A Brief History of Direct-to-Consumer Advertising of Prescription Drugs ↩︎
- McKinsey: Omnichannel Engagement in Pharma ↩︎
- Edelman Trust Barometer 2023 ↩︎